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Background: Surgery of locally advanced and/or recurrent rectal cancer can be complemented with intra-operative
electron radiation therapy (IOERT) to deliver a single dose of radiation directly to the unresectable margins, while
sparing nearby sensitive organs/structures. Haemorrhages may occur and can affect the dose distribution, leading to
an incorrect target irradiation. The TachoSil (TS) surgical patch, when activated, creates a fibrin clot at the surgical site
to achieve haemostasis. The aim of this work was to determine the effect of TS on the dose distribution, and ascertain
whether it could be used in combination with IOERT. This characterization was extended to include high dose rate
(HDR) intraoperative brachytherapy, which is sometimes used at other institutions instead of IOERT.
Methods: CT images of the TS patch were acquired for initial characterization. Dosimetric measurements were
performed in a water tank phantom, using a conventional LINAC with a hard-docking system of cylindrical applicators.
Percentage Depth Dose (PDD) curves were obtained, and measurements made at the depth of dose maximum for the
three clinically used electron energies (6, 9 and 12MeV), first without any attenuator and then with the activated patch of
TS completely covering the tip of the IOERT applicator. For HDR brachytherapy, a measurement setup was improvised
using a solid water phantom and a Farmer ionization chamber.
Results: Our measurements show that the attenuation of a TachoSil patch is negligible, both for high energy electron
beams (6 to 12MeV), and for a HDR 192Ir brachytherapy source. Our results cannot be extrapolated to lower beam
energies such as 50 kVp X-rays, which are sometimes used for breast IORT.
Conclusion: The TachoSil surgical patch can be used in IORT procedures using 6MeV electron energies or higher,
or HDR 192Ir brachytherapy.
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In intra-operative radiation therapy (IORT), ionizing ra-
diation is used during a surgical intervention [1,2]. After
removal of the neoplastic mass, the remaining area is ir-
radiated for direct treatment of the resection margins,
including positive margins, according to international
protocols [1].
Surgery of locally advanced and/or recurrent rectal
cancer can be complemented with intra-operative elec-
tron radiation therapy (IOERT). Sometimes, high-dose-rate
brachytherapy (IO-HDR) with a source of Iridium- 192
(192Ir) is used instead of IOERT [3]. Both modalities deliver
a single radiation dose directly to the malignant tissues,
while sparing nearby sensitive organs/structures [1,2].
Haemorrhages may occur in the pelvic area during a sur-
gery, or a haematic fluid build-up, which may affect the dose
distribution during irradiation if no haemostatic measures
are applied [4]. At our institution, surgery of locally ad-
vanced and/or recurrent rectal cancer is often complemen-
ted with IOERT, and fluid build-up is frequently observed.
The solution adopted is to use constant suction. However, a
residual accumulation of fluid generally remains.
TachoSil (Takeda Pharmaceuticals, Zurich, Switzerland)
is an absorbable fibrin sealant patch indicated for haemo-
stasis during surgical procedures [5,6]. To the authors’
knowledge, it has never been used in combination with
IORT, and its radiation attenuation properties have never
been measured or reported.
Since TachoSil (TS) has already proven useful in situa-
tions of pelvic bleeding [7,8], it seems reasonable to sup-
pose that this sealant patch could be beneficial in IORT, as
it would help minimize the fluid build-up by reducing the
bleeding in or near the irradiation target. Before initiating
clinical trials to assess its efficacy, safety and clinical rele-
vance, it is necessary first to measure the attenuation
properties of the TS patch, in order to determine whether
its presence will affect the dose distribution. This is par-
ticularly important in IOERT, where dose calculations are
performed manually, after visual estimation of the target
area. More sophisticated forms of treatment planning
would require computed tomography (CT) images of the
patient, which are difficult to obtain during a surgical pro-
cedure. Therefore, any additional attenuation must be
known in advance so it can be taken in consideration dur-
ing calculations.
The aim of this work is to characterize the effect of a
TachoSil (TS) patch on the dose distribution underneath
it, through detailed dosimetric measurements.
Methods
The TS patch is a white collagen sponge coated on one
side with a yellow layer of active components from human
blood, fibrinogen and thrombin. When the sponge comes
into contact with fluids (such as blood, lymph or salinesolution) the fibrinogen and the thrombin are activated
and form a fibrin network. This means the sponge sticks to
the tissue surface, the blood coagulates (local haemostasis)
and the tissue is sealed [8].
The inactivated (dry) patch was cut to size, activated
with saline solution and wrapped in very thin plastic film,
to permit easy manipulation (Figure 1A). Therefore, the
patch could be held in place at the end of an IOERT appli-
cator, as shown in Figure 1B, both for dosimetric measure-
ments and for acquisition of computed tomography (CT)
images. For initial characterization, CT images of dry and
activated TS were obtained using a Toshiba Asteion 4-slice
CT scanner in axial mode.
IORT procedures at our institution are always per-
formed with high energy electron beams (IOERT), using a
conventional linear accelerator (Varian 2100CD), with a
hard-docking system of cylindrical applicators, with diam-
eters ranging from 3 to 15 cm and bevel angles of 0, 15,
30 and 45° (Figure 1C). The available electron energies are
6, 9, 12, 15 and 18MeV, but only 6, 9 and 12MeV are used
for IOERT.
To determine the effect of TS on the IOERT dose distri-
bution, dosimetric measurements were performed in a
water tank phantom (MP3, PTW-Freiburg, Germany). The
applicator of 7 cm diameter, bevel angle of 0° was used for
the measurements, with source to surface distance (SSD)
of 134 cm. This is the reference SSD for this IOERT ap-
plicator system (usable SSDs range between 124 and
144 cm). Measurements were performed with an activated
patch completely covering the IOERT applicator opening
(Figure 1B) and without it. During measurements, either
the tip of the applicator, or the TachoSil covering it, were
in contact with the water surface (air gap = 0). Percentage
Depth Dose (PDD) curves were obtained for the three clin-
ically used electron energies (6, 9 and 12MeV) with a diode
detector (type 60012 E PTW-Freiburg, Germany). A
Markus ionization chamber (type N23343 PTW-Freiburg,
Germany) was then placed at the depth of dose maximum
(Dmax), and readings were obtained for 6, 9 and 12MeV,
first without attenuator and then with the activated patch
covering the tip of the applicator.
HDR brachytherapy with 192Ir is commonly performed
at our institution, although not for IORT. For a more
complete characterization and to anticipate future possibil-
ities, this modality was also considered in the present study.
Dosimetry for HDR brachytherapy is not usually done in
water phantom, therefore a measuring setup was impro-
vised using a white polystyrene phantom, also known as
solid water phantom (type RW3 PTW-Freiburg, Germany).
As shown in Figure 1D, one of the phantom slabs was
adapted to hold a brachytherapy applicator (needle), con-
nected by a cable to the afterloader device, which was pro-
grammed to position the 192Ir source at the centre of the
slab, for 60s, for each measurement. The detector used was
EBA C
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Figure 1 Experimental setup for dosimetric measurements with TachoSil in IOERT and in HDR 192Ir brachytherapy. (A) Activated TachoSil
patch wrapped in very thin plastic film. (B) Same patch covering the tip of a 7 cm IOERT applicator. (C) Water tank used for dosimetric measurements,
and the conventional LINAC adapted for IOERT with a hard-docking system of applicators. (D) Phantom slab adapted to hold HDR needle (E) Set-up
used to study the effect of TachoSil in treatments with 192Ir.
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Germany), placed inside the appropriate phantom slab.
Four 1 cm slabs were added between the slab containing
the needle and the one containing the Farmer chamber, as
shown in Figure 1E. The activated patch was placed at the
centre, between the second and third uniform slabs.
Spacers less than 1 mm thick were added so that measure-
ments could be performed with and without attenuator, at
the same source-to-detector distance.
Results and discussion
CT images
CT images provide information about the way a material
interacts with ionising radiation. This interaction de-
pends both on the electronic density of the material, and
on the type and energy of the incident radiation. There-
fore the relationship between CT numbers and electronic
density varies slightly between scanners and acquisition
protocols [9]. But within each CT image, materials with
similar electronic density will have similar CT numbers,
which in the context of this work is enough for compari-
son purposes. Typical CT numbers of relevant materials
are −1000 HU for air, 0 HU for water, +92 HU to +137
HU for acrylic, +100 HU to +300 HU for soft tissue
and −100 HU to – 50 HU for fat.
CT images of non-activated (dry) and activated (wet) TS
were obtained and are presented in Figure 2. CT numbers
for the non activated TachoSil patch are between −980HU and −900 HU (Figure 2C). The non activated patch is
originally 3 to 4 mm thick, but we observed that this
thickness is reduced to less than 1 millimetre when the
patch is activated. It is difficult to measure CT numbers
accurately for such a thin strip of material. The CT num-
bers for the activated patch appear to be −100 HU in
Figure 2B and −500 HU in Figure 2A. These results, and
the visual analysis of the images (Figure 2), suggest that
the electronic density of the patch increases with the acti-
vation process, probably due to the absorption of fluid,
but remains lower than that of acrylic or water, and conse-
quently lower than that of soft tissue.
Attenuation of high energy electron beams (IOERT)
The Percentage Depth Dose (PDD) curves measured in
water phantom without and with the TachoSil patch are
shown in Figure 3 for all three electron energies. No
significant difference was observed in PDDs obtained
with and without this attenuator. This is confirmed by
applying a gamma (γ) index analysis to compare both
PDD curves [10]. The gamma index distribution is pre-
sented in Figure 3, plotted in the same graph as the
PDDs. Acceptable limits for the distance and dose differ-
ences were set to 2 mm and 2%, respectively. 100% of
points pass the gamma test (γ ≤ 1) with these criteria.
The similarity of the PDD curves is consistent with
little or no attenuation of the TS patch. This is in good
agreement with the results presented in the previous
CB
A
Figure 2 CT images of non-activated and activated TachoSil. (A) Activated TachoSil placed on the tip of a 7 cm IOERT acrylic applicator. (B)
Same patch folded and immersed in water (C) Non-activated TachoSil inside its package, placed on top of a cylindrical acrylic phantom filled with
water. The desiccant included in the package is also clearly visible. The TachoSil patch is indicated by a white arrow.
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thin (<1 mm) strip of material with electronic density
lower than that of tissue.
The results of measurements performed with the Mar-
kus ionization chamber at the depth of dose maximum
(Dmax) are presented in Table 1, as chamber readings
corrected for the influence quantities temperature and
pressure. Readings were obtained first without attenu-
ator (M) and then with an activated patch covering the
applicator end (MT).
No significant differences were observed in absolute
measurements with and without TachoSil. All mea-
sured variations are within the experimental uncer-
tainty of ±0.1%, confirming that the attenuation of the
sealant patch is negligible for high energy electron
beams of 6 to 12MeV.
The displacement of water caused by the presence of the
sealant patch at the tip of the IOERT applicator was min-
imal. Nevertheless, to confirm that water displacement did
not mask the attenuation, the measurements at the depth
of dose maximum were repeated in a solid water phantom,
for 6 and 12MeV, with similar results. The highest variation
observed (−0.2% for 6MeV) was still within experimental
error (±0.1%).
According to these results, this surgical patch can be
used in combination with intra-operative electron radi-
ation therapy (IOERT), for electron energies of 6MeV or
higher, without any significant beam attenuation or alter-
ation of dose distribution.Attenuation of 192Ir (IO-HDR)
Percentage Depth Dose (PDD) curves were not obtained
for this modality, due to the different experimental setup
used. The Farmer ionization chamber readings obtained,
corrected for the influence quantities temperature and
pressure, are presented in Table 2.
When a TachoSil patch is placed between the phantom
slabs, the resulting attenuation is ~0.5%. This is higher
than observed for high energy electron beams, but still
lower than the admissible uncertainty for radiotherapy
output dose (2%). Even if more than one sealant patch is
used, with overlapping, the combined effect will still be
negligible. There is no need to account for added
attenuation during treatment planning.
Further considerations
According to the manufacturer, TachoSil is sterilized by
gamma irradiation after completion of inner and outer
packaging [11]. This sterilization is performed with a
source of Cobalt-60 (60Co) delivering doses of the order of
kGy [12]. Therefore, the effect of radiation on the surgical
patch itself was not studied, since it has already been sub-
jected to doses much higher than the 10–20 Gy typically
used in IORT treatments. Moreover, patch activation and
sealing effect will occur before the IORT irradiation.
Intra-operative electron radiation therapy (IOERT) can
be performed with conventional LINACs like ours, or with
dedicated mobile units such as NOVAC7, Mobetron and
LIAC. Mobile LINACs have higher dose rates [13,14] than
Figure 3 PDDs with and without TS for 7 cm applicator and 6, 9 and 12MeV electron energies. Differences between PDDs with and without TS
were evaluated by gamma function analysis (2%, 2 mm criteria), and the gamma (γ) index is plotted in the secondary axis.
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Table 1 Markus ionization chamber readings without (M)
and with TachoSil (MT)
Energy (MeV) Dmax (mm) M (nC) MT (nC) DifT
6 13 2.259 ± 0.003 2.258 ± 0.003 −0.1%
9 20 2.714 ± 0.003 2.716 ± 0.003 0.1%
12 27 3.015 ± 0.003 3.018 ± 0.003 0.1%
Markus readings corrected for the influence quantities of temperature and
pressure. Indicated uncertainty corresponds to the maximum fluctuation of
Markus chamber readings between measurements under the same conditions.
All MT vs M differences are within the experimental uncertainty of ± 0.003 nC
or ±0.1%.
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electron energies. For this reason, mobile LINACs were
not considered separately in the context of this work.
At our institution, 9MeV is the most commonly used
electron energy for pelvic IOERT, so the attenuation of
the sealant patch was determined only for electron ener-
gies of 6 to 12MeV. It is important to note that these at-
tenuation results cannot be extrapolated to lower electron
energies, and especially not for low energy X-rays, which
are sometimes used for breast IORT [15].
A preliminary assessment using a 50 kVp X-ray beam
from a conventional radiodiagnostic unit suggests that,
at such low beam energies, the attenuation could be as
high as 6%. Therefore, TachoSil must not be used in
IORT with low energy X-rays without further investiga-
tions, which fall outside the scope of the present work.
Conclusion
The activated TS patch is less than 1 millimetre thick. Even
after activation, its electronic density remains lower than
that of tissue. Our measurements confirm that the attenu-
ation of the TS patch is negligible for electron energies be-
tween 6MeV and 12MeV. Percentage Depth Dose (PDD)
curves obtained with and without attenuator are practically
coincident, and dose readings at Dmax remained constant
within experimental uncertainty. Moreover, the attenuation
of the TS patch was found to be ~0.5% for a HDR 192Ir
brachytherapy source, which is still negligible for the pur-
pose of treatment planning.
Therefore, the TachoSil surgical patch can be used
during IOERT and IO-HDR procedures, since it will not
alter the dose distribution. Our next step is to ascertain
the effectiveness, safety and clinical usefulness of this
sealant patch during IOERT of the pelvic region. Hope-
fully it will help control the build-up of fluid affectingTable 2 Farmer ionization chamber readings without (M)
and with TachoSil (MT)
M (nC) MT (nC) DifT
3.486 ± 0.001 3.469 ± 0.001 −0.5%the dose distribution, by minimizing the bleeding near
the irradiation target.
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